This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03909/identifier/pubchem-substance/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03909/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03909/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03909/identifier/bindingdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03909/identifier/pubchem-compound/

Statements

Subject Item
n2:DB03909
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB03909 n14:DB03909
dcterms:title
Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate
adms:identifier
n7:46506243 n8:ACP n9:46936826 n10:18135 n11:DB03909
n3:IUPAC-Name
n4:271B4EBA-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4EC0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4EBF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4EBC-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4EBD-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4EBE-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4EB8-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4EB9-363D-11E5-9242-09173F13E4C5 n4:271B4EB6-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4EB7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4EC6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4EC7-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4EC1-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4EC2-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4EC4-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4EC3-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4EC5-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4ECC-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4ECE-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4ECF-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4ECB-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4ECA-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4ECD-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4EBB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4EC8-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4EC9-363D-11E5-9242-09173F13E4C5